Pretrial Drug Testing and Release Violations in North Dakota
A positive screen, diluted urine result, missed collection, prescription issue, or drug-patch report can put pretrial release at risk before the…
Urine tests, drug patches, prescriptions, and release allegations
Pretrial Drug Testing and Release Violations in North Dakota
A positive screen, diluted urine result, missed collection, prescription issue, or drug-patch report can put pretrial release at risk before the underlying charge is resolved. The label on a supervision report is only the beginning. A lawyer should identify the written condition, the specimen and method, screening cutoff, confirmation process, chain of custody, medication history, collection facts, and the response the court is being asked to impose.
Common drug-testing methods
Urine immunoassay screening
A screening test detects a class of compounds above a cutoff. It is designed for speed and sensitivity, not final identification of every substance. A class screen may react to a target drug, metabolite, prescribed medication, or another compound. The report should identify the panel, cutoff, result, specimen validity information, and whether confirmation occurred.
Laboratory confirmation
Confirmation uses a more specific analytical method to identify and measure particular compounds. The laboratory should report the method, analyte, cutoff or reporting threshold, quantitative result when available, quality-control status, and reviewer. A positive screen that was never confirmed should be described accurately rather than presented as a definitive identification.
Oral-fluid testing
Oral fluid may reflect a different detection period and can reduce some collection concerns. Food, drink, dry mouth, collection volume, device performance, and timing can affect the process. Obtain the collection instructions, chain, screen, and confirmation data.
Drug patches
A patch remains on the skin and collects perspiration over days. The laboratory analyzes the patch for listed drugs or metabolites. Application, seal integrity, wear interval, environmental conditions, removal, packaging, shipping, and laboratory extraction all become part of the evidentiary sequence.
Hair testing and other matrices
Hair or another specimen may be used in some settings, although the written order and local program determine what is authorized. Detection periods, external contamination, cosmetic treatment, and laboratory washing procedures can matter. A result from one matrix should not be assumed to answer when or how a substance entered the body.
Screening, confirmation, and cutoffs
Many disputes begin because a summary uses the word “positive” without identifying the stage. Ask whether the result was an on-site cup, automated laboratory screen, confirmed analytical finding, or merely a presumptive field test.
A cutoff is not zero
Testing programs set decision thresholds. A reported negative does not necessarily prove no molecule was present, and a positive means the measured response met the applicable criterion. Different programs may use different cutoffs. Obtain the value actually used on the date of testing.
Drug class versus specific compound
A screen may say “amphetamines,” “opiates,” or “benzodiazepines,” while confirmation identifies particular substances or metabolites. Counsel should avoid treating the class label as proof of a specific illegal drug. Prescription review and metabolism depend on the actual compound.
Quantitative numbers require context
A concentration can be affected by dose, timing, metabolism, hydration, renal function, specimen type, and collection interval. One urine number ordinarily does not establish precise time of use or impairment without qualified interpretation. Trend comparisons also require consistent methods and validity data.
Laboratory comments and flags
Reports may contain qualifiers for interference, insufficient quantity, invalidity, below-limit findings, or pending confirmation. Obtain the complete report with footnotes. A database entry or supervision screenshot may omit the qualification that changes the meaning.
Collection, chain of custody, and specimen validity
A reliable analytical method cannot cure a specimen mix-up. Follow the sample from identification through reporting.
Identity and labeling
Review photo identification, collector initials, specimen number, seal numbers, times, signatures, and electronic accession records. Compare the number on the collection form with the laboratory report. An unexplained discrepancy warrants investigation; a minor clerical error does not automatically prove the wrong sample was tested.
Temperature and observation
Urine temperature may be recorded shortly after collection. Direct observation, monitored collection, or unobserved collection may be used depending on rules and circumstances. Obtain the actual observation note rather than assume a flagged result means substitution.
Dilute specimens
Dilution is generally assessed using measures such as creatinine and specific gravity. It can result from intentional water loading, ordinary hydration, medical conditions, medication, strenuous activity, or collection timing. The participant rules may classify dilute samples separately. Medical evaluation and complete validity numbers are more useful than speculation.
Invalid, adulterated, or substituted labels
These are technical classifications with defined criteria. Ask which measurement triggered the classification, the method, quality control, and whether the specimen was retested. Do not allow “invalid” to be restated as “positive” or “tampered” without supporting facts.
Transport and storage
Review sealing, refrigeration when required, courier transfer, accession, storage temperature, and time to analysis. Stability differs by compound and specimen. A general chain form may be sufficient unless the defense identifies a concrete break or condition capable of affecting the result.
Prescriptions, over-the-counter products, and supplements
Rule 46’s listed condition distinguishes nonprescribed controlled substances. A valid prescription can therefore be central, but it must match the drug, person, timing, and directions.
Verify the prescription
Collect the pharmacy profile, bottle label, prescriber record, fill date, dose, and directions. A medication prescribed years earlier, obtained from another person, or used contrary to instructions may not resolve the allegation. Counsel should identify what the order says about misuse and disclosure.
Metabolites can be confusing
A prescribed drug can produce a metabolite associated with another name, and some substances share metabolic products. Confirmation records and qualified toxicological interpretation are necessary. Internet charts and package claims are not substitutes for the laboratory’s analyte data.
Over-the-counter medicine
Some nonprescription products can cross-react on screens. The specific brand, formulation, lot, dose, and timing matter. Preserve packaging and receipts. A confirmed result may distinguish the target from a cross-reactant, which is why the confirmation status is critical.
Supplements and unregulated products
Products marketed as herbal, hemp-derived, workout, sleep, or weight-loss supplements may contain ingredients not obvious from advertising. “Legal at the store” does not guarantee compliance with a court order or a negative test. Preserve the exact product, label, lot, and purchase record; do not continue using it while the issue is unresolved.
Medical confidentiality
Release disputes do not require indiscriminate disclosure of an entire medical history. Counsel can provide targeted prescription verification, seek a protective approach, or ask for limited review. The court still needs enough reliable information to evaluate the claimed explanation.
Missed, late, refused, and incomplete tests
A missed test can be treated as seriously as a positive because random testing depends on prompt collection. The defense should determine what actually happened.
Notice of the test
Obtain call logs, text notifications, application records, voicemail, reporting instructions, and the deadline. Was notice sent to the registered number? Did the participant have to check an automated line? Did the schedule change? A credible defense needs the actual notification history.
Ability to report
Medical emergency, custody in another jurisdiction, weather closure, transportation failure, work confinement, or facility error may explain nonappearance. Preserve independent proof. Ordinary inconvenience may not excuse the miss, especially when the participant failed to call.
Late arrival and facility refusal
Document arrival time, staff statements, posted hours, surveillance, location data, and whether an alternate site was requested. Do not argue or leave without obtaining a name or written notation. Contact supervision immediately and follow the direction for a make-up test.
Unable to provide a sample
A person may experience a medical or anxiety-related inability to urinate. Follow the collection protocol, remain as instructed, and request medical documentation if recurrent. Leaving early can be reported as refusal. Excessive fluid consumption may create a dilute result.
Continue testing
One missed test does not authorize abandoning the program. Report for every later test. Prompt, complete compliance can limit the dispute and supports a proposed release plan even if the court finds the original miss occurred.
Drug-patch allegations require their own analysis
A patch integrates exposure over a wear period rather than identifying a single moment. The record should show application, serial or specimen identifier, skin preparation, dates, condition at removal, packaging, shipment, and analysis.
Application and seal
Determine who applied the patch, whether the skin was cleaned according to procedure, and whether edges remained sealed. Photographs and service notes may show lifting, sweat, abrasion, rash, or damage. Report problems rather than reattaching or covering the patch independently.
Environmental contamination
External contact is a fact-specific claim. Identify the substance, setting, duration, protective clothing, patch condition, and laboratory washing procedure. The court will need more than the possibility that contamination can occur.
Wear interval
Longer or irregular wear may affect collection and physical condition. Compare actual dates with the program schedule and laboratory validation. Determine whether a late removal was caused by the participant, agency scheduling, closure, or another event.
What the result cannot date precisely
A positive patch generally concerns the wear period. Without additional evidence it may not establish the exact day, dose, or impairment. That limitation can matter to an allegation tied to a specific event, while still leaving a broader abstinence issue.
Records to request after an alleged violation
- The signed release order, amendments, testing schedule, and participant rules.
- Notification history and attendance records.
- Collection form, specimen identifiers, seals, temperature, observation, and validity data.
- Screening instrument, panel, cutoff, calibration or quality-control status, and raw response.
- Confirmation method, analytes, quantitative results, thresholds, chromatograms or instrument data when relevant, and reviewer notes.
- Chain-of-custody, accession, storage, transport, and disposal records.
- Patch application and removal records, photographs, packaging, wear interval, and laboratory procedure.
- Prescription verification, pharmacy history, medical records, and preserved product packaging.
- Supervision notes, warning history, communications, and the complete violation report.
- Any later test that bears on the timing or reliability dispute.
Send preservation requests promptly. Laboratories have retention schedules for specimens and instrument data. A retest or independent review may become impossible after disposal. Counsel should decide whether the defense needs the remaining sample preserved before requesting broad handling.
Build one chronological evidence table
Testing records often come from several systems that use different identifiers and timestamps. Put the notification, collection, accession, screen, confirmation, laboratory review, agency receipt, client notice, and court report in a single chronology. Note the time zone and distinguish specimen time from result-release time. This exercise frequently reveals that a report described a preliminary screen as final, that confirmation arrived after custody was ordered, or that the agency associated a result with the wrong testing window.
Preserve the specimen before requesting destructive retesting
An independent laboratory may be able to examine a remaining aliquot, patch, or other sample, but the defense must learn how much remains and what testing would consume. A preservation request can instruct the custodian not to discard or exhaust the material. Counsel should consult a qualified laboratory about method, amount, storage, shipping, accreditation, and chain of custody before arranging a transfer.
Use an expert for the question actually disputed
Not every case needs an expert. A pharmacy record may resolve an undisclosed-prescription issue, and a facility log may resolve a missed-test allegation. Technical disputes about cross-reactivity, metabolites, specimen validity, patch contamination, analytical interference, or time-of-use claims may require a toxicologist or laboratory professional. Give the reviewer the raw data and complete records, not only the defense summary.
Compare reports with the laboratory’s own procedure
Request the standard operating procedure in effect on the test date when a material step is disputed. Identify the precise deviation and why it could affect the result. Courts are less persuaded by a checklist of harmless paperwork omissions than by a documented failure involving identity, calibration, quality control, confirmation, stability, or interpretation.
How an alleged test violation reaches court
Supervision may issue a warning, increase testing, request a warrant, or ask the prosecutor to seek revocation. The judge may continue release, add conditions, change the testing method, increase security, order treatment, or return the person to custody.
Pretrial release procedure is flexible
Rule 46 permits consideration of information outside formal trial evidence rules. Defense counsel should focus on the reliability problem and proposed remedy. If confirmation is pending, ask the court to reserve a final finding and use a temporary condition rather than treat the screen as conclusive.
Demand a clear allegation
“Failed test” can mean positive screen, confirmed substance, dilution, invalid specimen, missed appointment, late arrival, refusal, patch damage, or undisclosed prescription. The response and proof differ. The notice should state the date, conduct, test, and violated term.
Present mitigation without conceding the dispute
A defense lawyer can propose increased testing, a different matrix, treatment evaluation, prescription monitoring, or closer reporting while maintaining that the State has not established drug use. Courts often need a practical answer to risk in addition to legal criticism of the report.
Protect the underlying defense
The client’s testimony may affect the pending criminal case or a new possession allegation. Statements to collectors and supervision can be offered later. Counsel should determine what evidence can be presented through records, witnesses, or expert review without unnecessary admissions.
Common defense issues in disputed drug-test cases
No confirmed identification
A presumptive class screen may be insufficient for the requested consequence when confirmation was available but not performed. The defense should not overstate the point: release courts have flexible information rules. Explain the actual uncertainty and propose confirmation.
Prescription or documented cross-reactivity
Match the medication and timing to the laboratory data. A prescription defense is strongest when supported by pharmacy and prescriber records and consistent with the identified analyte. A broad list of possible false positives carries less weight.
Specimen identity or chain problem
Show the specific mismatch, missing seal, impossible time, or unexplained transfer. Courts distinguish a meaningful break from harmless paperwork. If another specimen could have been substituted, explain how the record supports that inference.
Medical explanation for validity result
Kidney conditions, fluid instructions, pregnancy, medications, or other facts may affect urine concentration. Obtain qualified medical support. A participant’s belief that they “drink a lot of water” is usually not enough to resolve a dilute classification.
Lack of notice or inability to test
Use phone records, application logs, facility records, custody records, weather notices, medical proof, and transportation evidence. Also show prompt reporting and later compliance. Silence after a missed window can undermine an otherwise legitimate explanation.
Order does not cover the alleged conduct
Compare the written condition with the theory. A legal noncontrolled product may still violate a broad sobriety condition, but not every testing anomaly equals use of a prohibited drug. The court can clarify future terms without finding a past breach unsupported by the order.
Seeking a different testing plan
Rule 46(a)(6) allows amendment at any time. A motion can address medical inability to provide urine, incompatible work schedules, distance, cost, recurring dilute specimens, patch dermatitis, or another documented problem.
Propose an available substitute: oral fluid, an adjusted random window, a closer approved site, observed collection with medical accommodation, more frequent tests of a different matrix, or treatment-linked monitoring. The proposal must preserve randomness and reliability. A request for “no testing” is less persuasive when a different method solves the problem.
Provide records and a compliance history. Explain how results will be reported, who pays, and what happens after a missed test. Do not switch laboratories or methods without written authorization. Private testing may supply useful evidence but does not replace the court-ordered program unless the judge says it does.
North Dakota cases and procedural principles
Published North Dakota appellate decisions about testing often arise after conviction, so their procedures should not be imported wholesale into pretrial release. They remain useful for understanding the consequences of supervision allegations and the importance of a developed record.
State v. Miller, 2025 ND 188
In State v. Miller, 2025 ND 188, ¶¶ 8–10, repeated failed 24/7 breath tests were part of a larger probation-revocation record. The defendant admitted the violations. The case shows why repeated noncompliance can accumulate, but it does not decide the proof needed when a person timely disputes a specific laboratory result.
Interest of A.R., 2009 ND 192, 775 N.W.2d 149
Interest of A.R., 2009 ND 192, ¶¶ 8–10, explains that a supervision sanction and later revocation are not a second criminal prosecution for double-jeopardy purposes. Although it involved juvenile drug court, the opinion illustrates that a testing or program event can have supervision consequences distinct from a new substantive case.
Rule 46 remains the pretrial anchor
Pretrial decisions should return to the actual release order and Rule 46. The judge can amend conditions, and information need not satisfy trial evidence rules. The defense should pair technical accuracy with a concrete plan that addresses appearance and safety.
Frequently asked questions about North Dakota pretrial drug testing
Is a positive screen the same as a confirmed test?
No. A screen usually detects a drug class above a cutoff. Confirmation uses a more specific method to identify particular compounds. Ask whether confirmation was performed and obtain the full report.
Can prescription medication cause a positive result?
Yes, depending on the medication and test. Verify the prescription, dose, fill date, and identified analyte. A valid prescription does not excuse misuse or a broader condition that the order clearly imposes.
What does “dilute” mean?
It refers to specimen-validity measurements showing low concentration, commonly using creatinine and specific gravity. Hydration, medical issues, or intentional water loading may be relevant. Obtain the actual numbers and program rule.
Is a dilute sample automatically positive?
No. Dilute describes specimen concentration, not identification of a drug. The program may separately treat it as noncompliance or require recollection. The report and order determine the allegation.
Can over-the-counter medicine affect a screen?
Some products may cross-react. Preserve the exact brand, formulation, lot, receipt, dose, and timing. Confirmation may distinguish the target drug from the other compound.
What should I do after missing a test?
Contact the required agency immediately, document why you missed it, follow instructions for a make-up test, notify counsel, and attend every later test. Do not fabricate an explanation or abandon testing.
Can a missed test lead to a warrant?
Yes. A missed required test can be alleged as a release violation. The court may issue a warrant, impose custody, or change conditions. Prompt documentation and a workable plan matter.
What if the test site was closed?
Photograph posted hours if lawful, save calls and location data, obtain staff names, contact supervision immediately, and ask for an alternate collection. Facility records can verify closure.
Can I use a private test to disprove the result?
A prompt independent test may be relevant, but different specimens and detection periods limit comparison. It does not replace court-ordered testing. Counsel should coordinate timing and documentation.
How long can drugs be detected?
There is no single period. It depends on the substance, metabolite, dose, frequency, specimen, cutoff, metabolism, and collection timing. Avoid precise claims without qualified analysis.
Can a drug patch show the exact day of use?
Usually it reports the wear interval rather than a precise day. Other evidence may narrow timing. Obtain the application, removal, seal, shipping, and laboratory records.
What if the patch causes a rash?
Report it promptly, document it, and seek medical care. Do not remove or cover the patch without authorization. Counsel can request replacement or a different testing method.
Can CBD or hemp products cause problems?
They can contain cannabinoids or unexpected ingredients and may conflict with the order. Store legality is not a guarantee. Preserve the product and lot information and stop use while seeking advice.
Does the State have to follow trial evidence rules at a bond hearing?
Rule 46 says release information need not conform to formal evidence rules. The defense can still challenge reliability, demand context, and ask the court to await confirmation before making a final finding.
Can the court change the testing method?
Yes. Rule 46(a)(6) permits amendment. Provide medical, work, distance, cost, or reliability evidence and propose a specific approved alternative.
Should I disclose prescriptions before testing?
Follow the program’s written process. Keep an updated pharmacy list and prescriber information. Do not hand over unrelated medical records without understanding the request and consulting counsel when needed.
What records should my lawyer obtain?
The order, program rules, notifications, collection and chain forms, validity data, screen, confirmation, raw instrument information when relevant, quality control, analyst notes, prescriptions, and supervision report.
Can I stop testing because I contest the result?
No. Continue until the judge changes the order. Stopping can create additional violations and weaken the request for release. Contest the result through records, qualified review, and court procedure.